There is no Press for this Ticker
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.

Related Companies

TickerCompanyChg %Mkt Cap
RVXCFResverlogix0.54%170.6M

Resverlogix Company Questions & Answers

Q

How do I buy Resverlogix (RVXCF) stock?

A

You can purchase shares of Resverlogix (OTC: RVXCF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Resverlogix's (RVXCF) main competitors?

A

There are no as such competitors for Resverlogix.

Q

What is the target price for Resverlogix?

A

There is no analysis for Resverlogix

Q

How much is Resverlogix (RVXCF) stock ?

A

The stock price for Resverlogix (OTC: RVXCF) is $0.7259 last updated Wed May 05 2021 19:22:13 GMT+0000 (Coordinated Universal Time).

Q

When is the next Resverlogix (RVXCF) dividend?

A

There are no upcoming dividends for Resverlogix.

Q

When is Resverlogix (OTC:RVXCF) reporting earnings?

A

There are no earnings for Resverlogix

Q

When is the upcoming split for RVXCF?

A

There is no upcoming split for Resverlogix.